UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Construction of hierarchical yolk-shell structured Mn3O4@NC as efficient sulfur hosts for Li–S batteries

Ceramics international, 2022-03, Vol.48 (5), p.6470-6476

2022

Volltextzugriff (PDF)

ZnTe/rGO Composite as the Fully Zinced Conversion‐Type Cathodes for Aqueous Zinc Ion Batteries

Chemistry : a European journal, 2023-02, Vol.29 (12), p.e202203339-n/a

2023

Volltextzugriff (PDF)

Visiting Znte as the Fully-Zinced Conversion-Type Cathodes for Aqueous Zinc Ion Batteries

SSRN Electronic Journal

Volltextzugriff (PDF)

Degradation of intracellular TGF-β1 by PROTACs efficiently reverses M2 macrophage induced malignant pathological events

Chemical communications (Cambridge, England), 2020-03, Vol.56 (19), p.2881-2884

2020

Volltextzugriff (PDF)

Novel cardioprotective mechanism for Empagliflozin in nondiabetic myocardial infarction with acute hyperglycemia

Biomedicine & pharmacotherapy, 2022-10, Vol.154, p.113606-113606, Article 113606

2022

Volltextzugriff (PDF)

Efficacy and safety of tislelizumab plus lenvatinib as first-line treatment in patients with unresectable hepatocellular carcinoma: a multicenter, single-arm, phase 2 trial

BMC medicine, 2024-04, Vol.22 (1), p.172-172, Article 172

2024

Volltextzugriff (PDF)

Dynamic radiological features predict pathological response after neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma

Journal of translational medicine, 2024-05, Vol.22 (1), p.471-471, Article 471

2024

Volltextzugriff (PDF)

Micro-topography dominated microhabitat significantly influences colonization and development of incubated-cyanobacteria biocrusts in a harsh sandy desert environment

Applied soil ecology : a section of Agriculture, ecosystems & environment, 2023-08, Vol.188, p.104874, Article 104874

2023

Volltextzugriff (PDF)

Endovascular treatment of aorto-iliac occlusive disease with TASC II C and D lesions: 10 year's experience of clinical technique

BMC cardiovascular disorders, 2023-02, Vol.23 (1), p.71-7, Article 71

2023

Volltextzugriff (PDF)

KN026 (anti-HER2 bispecific antibody) in patients with previously treated, advanced HER2-expressing gastric or gastroesophageal junction cancer

European journal of cancer (1990), 2023-01, Vol.178, p.1-12

2023

Volltextzugriff (PDF)

The importance of the IL‐1 family of cytokines in nanoimmunosafety and nanotoxicology

Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology, 2022-11, Vol.14 (6), p.e1850-n/a

2022

Volltextzugriff (PDF)

Advances and prospects of drug clinical research in colorectal cancer in 2022

Cancer innovation (Print), 2023-04, Vol.2 (2), p.99-113

2023

Volltextzugriff (PDF)

Phase 1b/2 trial of fruquintinib plus sintilimab in treating advanced solid tumours: The dose-escalation and metastatic colorectal cancer cohort in the dose-expansion phases

European journal of cancer (1990), 2023-03, Vol.181, p.26-37

2023

Volltextzugriff (PDF)

EGCG suppresses PD-1 expression of T cells via inhibiting NF-κB phosphorylation and nuclear translocation

International immunopharmacology, 2024-05, Vol.133, p.112069, Article 112069

2024

Volltextzugriff (PDF)

Design and Discovery of Natural Cyclopeptide Skeleton Based Programmed Death Ligand 1 Inhibitor as Immune Modulator for Cancer Therapy

Journal of medicinal chemistry, 2020-10, Vol.63 (19), p.11286-11301

2020

Volltextzugriff (PDF)

Efficacy and safety of surufatinib plus toripalimab in previously treated advanced tumors progressing after immunotherapy

Journal of clinical oncology, 2024-08, Vol.42 (23_suppl), p.36-36

2024

Volltextzugriff (PDF)

China special issue on gastrointestinal tumor: Regulatory-immunoscore-A novel indicator to guide precision adjuvant chemotherapy in colorectal cancer

International journal of cancer, 2023-12

2023

Volltextzugriff (PDF)

Camrelizumab combined with ablation and chemotherapy for pancreatic cancer with liver metastases: A single-arm, phase II, prospective clinical study

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.TPS4169-TPS4169

2021

Volltextzugriff (PDF)

Comparative efficacy and toxicity of immune checkpoint inhibitors in combination with or without chemotherapy treatment for advanced esophageal squamous cell carcinoma: A systematic review and meta-analysis

Frontiers in oncology, 2022-11, Vol.12, p.958783

2022

Volltextzugriff (PDF)

Nano-assemblies overcome cancer multidrug resistance for effectively synergistic chemo-immuno-oncotherapy

Chemical engineering journal (Lausanne, Switzerland : 1996), 2024-06, Vol.490, p.151437, Article 151437

2024

Volltextzugriff (PDF)

Combined Ultrasound and CT-Guided Iodine-125 Seeds Implantation for Treatment of Residual Hepatocellular Carcinoma Located at Complex Sites After Transcatheter Arterial Chemoembolization

Frontiers in oncology, 2021-03, Vol.11, p.582544-582544

2021

Volltextzugriff (PDF)

Updated efficacy and safety results from a phase 1b study of the PD-1 antagonist CS1003 combined with lenvatinib (LEN) as first-line (1L) treatment in Chinese patients (pts) with unresectable hepatocellular carcinoma (uHCC)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e16191-e16191

2022

Volltextzugriff (PDF)

China special issue on gastrointestinal tumors‐Regulatory‐immunoscore—A novel indicator to guide precision adjuvant chemotherapy in colorectal cancer

International journal of cancer, 2023-12, Vol.153 (11), p.1904-1915

2023

Volltextzugriff (PDF)

First-in-human dose escalation and expansion study of SYSA1801, an antibody-drug conjugate targeting claudin 18.2 in patients with resistant/refractory solid tumors

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.3016-3016

2023

Volltextzugriff (PDF)

Strengthening the Combinational Immunotherapy from Modulating the Tumor Inflammatory Environment via Hypoxia‐Responsive Nanogels

Advanced healthcare materials, 2024-03, Vol.13 (8), p.e2302865-n/a

2024

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(41)
Tagungsberichte
(3)

Sprache

Englisch
(43)
Chinesisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Construction of hierarchical yolk-shell structured Mn3O4@NC as efficient sulfur hosts for Li–S batteries

ZnTe/rGO Composite as the Fully Zinced Conversion‐Type Cathodes for Aqueous Zinc Ion Batteries

Visiting Znte as the Fully-Zinced Conversion-Type Cathodes for Aqueous Zinc Ion Batteries

Degradation of intracellular TGF-β1 by PROTACs efficiently reverses M2 macrophage induced malignant pathological events

Novel cardioprotective mechanism for Empagliflozin in nondiabetic myocardial infarction with acute hyperglycemia

Efficacy and safety of tislelizumab plus lenvatinib as first-line treatment in patients with unresectable hepatocellular carcinoma: a multicenter, single-arm, phase 2 trial

Dynamic radiological features predict pathological response after neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma

Micro-topography dominated microhabitat significantly influences colonization and development of incubated-cyanobacteria biocrusts in a harsh sandy desert environment

Endovascular treatment of aorto-iliac occlusive disease with TASC II C and D lesions: 10 year's experience of clinical technique

KN026 (anti-HER2 bispecific antibody) in patients with previously treated, advanced HER2-expressing gastric or gastroesophageal junction cancer

The importance of the IL‐1 family of cytokines in nanoimmunosafety and nanotoxicology

Advances and prospects of drug clinical research in colorectal cancer in 2022

Phase 1b/2 trial of fruquintinib plus sintilimab in treating advanced solid tumours: The dose-escalation and metastatic colorectal cancer cohort in the dose-expansion phases

EGCG suppresses PD-1 expression of T cells via inhibiting NF-κB phosphorylation and nuclear translocation

Design and Discovery of Natural Cyclopeptide Skeleton Based Programmed Death Ligand 1 Inhibitor as Immune Modulator for Cancer Therapy

Efficacy and safety of surufatinib plus toripalimab in previously treated advanced tumors progressing after immunotherapy

China special issue on gastrointestinal tumor: Regulatory-immunoscore-A novel indicator to guide precision adjuvant chemotherapy in colorectal cancer

Camrelizumab combined with ablation and chemotherapy for pancreatic cancer with liver metastases: A single-arm, phase II, prospective clinical study

Comparative efficacy and toxicity of immune checkpoint inhibitors in combination with or without chemotherapy treatment for advanced esophageal squamous cell carcinoma: A systematic review and meta-analysis

Nano-assemblies overcome cancer multidrug resistance for effectively synergistic chemo-immuno-oncotherapy

Combined Ultrasound and CT-Guided Iodine-125 Seeds Implantation for Treatment of Residual Hepatocellular Carcinoma Located at Complex Sites After Transcatheter Arterial Chemoembolization

Updated efficacy and safety results from a phase 1b study of the PD-1 antagonist CS1003 combined with lenvatinib (LEN) as first-line (1L) treatment in Chinese patients (pts) with unresectable hepatocellular carcinoma (uHCC)

China special issue on gastrointestinal tumors‐Regulatory‐immunoscore—A novel indicator to guide precision adjuvant chemotherapy in colorectal cancer

First-in-human dose escalation and expansion study of SYSA1801, an antibody-drug conjugate targeting claudin 18.2 in patients with resistant/refractory solid tumors

Strengthening the Combinational Immunotherapy from Modulating the Tumor Inflammatory Environment via Hypoxia‐Responsive Nanogels

Suchergebnisse filtern